{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:05:06Z","timestamp":1792512306146,"version":"4.5.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"am","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.cardfail.2022.09.018","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T04:13:05Z","timestamp":1678767185000},"page":"375-388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Epidemiology, Pathophysiology, Diagnosis, and Therapy of Heart Failure With Preserved Ejection Fraction in Japan"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5473-0688","authenticated-orcid":false,"given":"MASARU","family":"OBOKATA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIDEMI","family":"SORIMACHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TOMONARI","family":"HARADA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KAZUKI","family":"KAGAMI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUKI","family":"SAITO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIDEKI","family":"ISHII","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2022.09.018_bib0001","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart Disease and Stroke Statistics: 2021 Update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0002","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41569-020-0363-2","article-title":"Evaluation and management of heart failure with preserved ejection fraction","volume":"17","author":"Borlaug","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0003","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1093\/eurheartj\/ehy301","article-title":"Heart failure with preserved ejection fraction: From mechanisms to therapies","volume":"39","author":"Lam","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0004","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/S0140-6736(15)00516-4","article-title":"The world report on ageing and health: a policy framework for healthy ageing","volume":"387","author":"Beard","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0005","year":"2021","journal-title":"Government of Japan. Report on Aging Society"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0006","unstructured":"United Nations: Department of Economic and Social. World Population Ageing, 2019."},{"key":"10.1016\/j.cardfail.2022.09.018_bib0007","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1253\/circj.CJ-11-0135","article-title":"CHART-2 Investigators. Trend of Westernization of etiology and clinical characteristics of heart failure patients in Japan: first report from the CHART-2 study","volume":"75","author":"Shiba","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0008","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1253\/circj.72.489","article-title":"Impending epidemic: future projection of heart failure in Japan to the year 2055","volume":"72","author":"Okura","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0009","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ejhf.1227","article-title":"Heart failure with preserved ejection fraction in Asia","volume":"21","author":"Tromp","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0010","first-page":"606","article-title":"Forecasting the impact of heart failure in the United States","volume":"6","author":"Bluemke","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0011","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/CIRCULATIONAHA.118.035858","article-title":"Current status of cardiovascular medicine in the aging society of Japan","volume":"138","author":"Yasuda","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0012","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/ehf2.13844","article-title":"Prevalence and prognostic impact of cognitive frailty in elderly patients with heart failure: sub-analysis of FRAGILE-HF","volume":"9","author":"Yamamoto","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0013","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1253\/circj.CJ-20-0947","article-title":"Clinical characteristics and outcomes of hospitalized patients with heart failure from the large-scale Japanese Registry Of Acute Decompensated Heart Failure (JROADHF)","volume":"85","author":"Ide","year":"2021","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0014","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1536\/ihj.21-486","article-title":"Impact of left ventricular chamber size on outcome in heart failure with preserved ejection fraction","volume":"63","author":"Ogawa","year":"2022","journal-title":"Int Heart J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0015","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1253\/circj.CJ-17-1386","article-title":"Demographics, management, and in-hospital outcome of hospitalized acute heart failure syndrome patients in contemporary real clinical practice in Japan: observations from the prospective, multicenter Kyoto Congestive Heart Failure (KCHF) registry","volume":"82","author":"Yaku","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0016","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1253\/circj.CJ-09-0254","article-title":"Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction: report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD)","volume":"73","author":"Tsuchihashi-Makaya","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0017","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/ejhf.807","article-title":"Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study","volume":"19","author":"Tsuji","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0018","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ehf2.12418","article-title":"Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan","volume":"6","author":"Shiga","year":"2019","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0019","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/ehf2.12500","article-title":"Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid-range and preserved ejection fraction","volume":"6","author":"Ueda","year":"2019","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0020","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1253\/circj.CJ-18-0881","article-title":"Different impact of changes in left ventricular ejection fraction between heart failure classifications in patients with acute decompensated heart failure","volume":"83","author":"Yamamoto","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0021","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/ejhf.559","article-title":"Clinical significance of pulse pressure in patients with heart failure with preserved left ventricular ejection fraction","volume":"18","author":"Tokitsu","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0022","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1002\/ehf2.12867","article-title":"Prognostic impact of mineralocorticoid receptor antagonist in patients with heart failure with preserved ejection fraction","volume":"7","author":"Suzuki","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0023","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/ehf2.13885","article-title":"Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction","volume":"9","author":"Hamada","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0024","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jjcc.2021.12.002","article-title":"Efficacy of renin-angiotensin-aldosterone-system inhibitors for heart failure with preserved ejection fraction and left ventricular hypertrophy: from the KUNIUMI Registry Acute Cohort","volume":"79","author":"Odajima","year":"2022","journal-title":"J Cardiol"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002916","article-title":"Association of obesity with heart failure outcomes in 11 Asian regions: a cohort study","volume":"16","author":"Chandramouli","year":"2019","journal-title":"PLos Med"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0026","unstructured":"Ministry of Health, Labour and Welfare of Japan. National Health and Nutrition Survey Report 2019. n.d."},{"key":"10.1016\/j.cardfail.2022.09.018_bib0027","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jchf.2018.07.009","article-title":"Adiposity and incident heart failure and its subtypes","volume":"6","author":"Rao","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0028","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.hfc.2020.02.004","article-title":"Obesity-related heart failure with preserved ejection fraction","volume":"16","author":"Harada","year":"2020","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0029","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.hfc.2021.02.009","article-title":"Clinical phenogroups in heart failure with preserved ejection fraction","volume":"17","author":"Sorimachi","year":"2021","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0031","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.mayocp.2018.11.037","article-title":"Characterization of the obese phenotype of heart failure with preserved ejection fraction: a RELAX trial ancillary study","volume":"94","author":"Reddy","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0032","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jchf.2020.04.016","article-title":"Hemodynamic and functional impact of epicardial adipose tissue in heart failure with preserved ejection fraction","volume":"8","author":"Koepp","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0033","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/ejhf.2254","article-title":"Obesity, venous capacitance, and venous compliance in heart failure with preserved ejection fraction","volume":"23","author":"Sorimachi","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0034","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0035","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/cvr\/cvaa217","article-title":"Metabolic inflammation in heart failure with preserved ejection fraction","volume":"117","author":"Schiattarella","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0036","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/eurheartj\/ehaa823","article-title":"Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction","volume":"42","author":"Sorimachi","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0037","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1089\/met.2017.0132","article-title":"International comparison of abdominal fat distribution among four populations: The ERA-JUMP study","volume":"16","author":"Kadowaki","year":"2018","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0038","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1002\/ehf2.13071","article-title":"Pathophysiological role of fatty acid-binding protein 4 in Asian patients with heart failure and preserved ejection fraction","volume":"7","author":"Harada","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0039","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00259-021-05280-9","article-title":"Abdominal obesity, and not general obesity, is associated with a lower 123I MIBG heart-to-mediastinum ratio in heart failure patients with preserved ejection fraction","volume":"49","author":"Sunaga","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jchf.2016.09.015","article-title":"Prevalence and clinical significance of diabetes in Asian versus white patients with heart failure","volume":"5","author":"Bank","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0041","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2944","article-title":"High genetic risk scores for impaired insulin secretory capacity doubles the risk for type 2 diabetes in Asians and is exacerbated by Western-type diets","volume":"34","author":"Kim","year":"2018","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0042","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013114","article-title":"Association of diabetes mellitus on cardiac remodeling, quality of life, and clinical outcomes in heart failure with reduced and preserved ejection fraction","volume":"8","author":"Yap","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0043","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jacc.2014.05.030","article-title":"Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study","volume":"64","author":"Lindman","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2017.07.012","article-title":"Distinct myocardial targets for diabetes therapy in heart failure with preserved or reduced ejection fraction","volume":"6","author":"Paulus","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0045","doi-asserted-by":"crossref","first-page":"I31","DOI":"10.1161\/CIRCULATIONAHA.106.680157","article-title":"Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes","volume":"116","author":"Boodhwani","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0046","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacc.2018.04.039","article-title":"Myocardial injury and cardiac reserve in patients with heart failure and preserved ejection fraction","volume":"72","author":"Obokata","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0047","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12928-021-00832-0","article-title":"Japanese nationwide PCI (J-PCI) Registry Annual Report 2019: patient demographics and in-hospital outcomes","volume":"37","author":"Ando","year":"2022","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0048","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","article-title":"Chronic kidney disease and coronary artery disease: JACC state-of-the-art review","volume":"74","author":"Sarnak","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0049","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/ejhf.1945","article-title":"Prognostic impacts of dynamic cardiac structural changes in heart failure patients with preserved left ventricular ejection fraction","volume":"22","author":"Yamanaka","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0050","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12968-021-00807-3","article-title":"Cardiovascular magnetic resonance assessment of coronary flow reserve improves risk stratification in heart failure with preserved ejection fraction","volume":"23","author":"Kato","year":"2021","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0051","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/ejhf.1926","article-title":"Prevalence and prognostic impact of the coexistence of multiple frailty domains in elderly patients with heart failure: the FRAGILE-HF cohort study","volume":"22","author":"Matsue","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0052","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1002\/ehf2.13482","article-title":"Prognostic impact of Clinical Frailty Scale in patients with heart failure with preserved ejection fraction","volume":"8","author":"Sunaga","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0053","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005254","article-title":"Physical function, frailty, cognition, depression, and quality of life in hospitalized adults \u226560 years with acute decompensated heart failure with preserved versus reduced ejection fraction","volume":"11","author":"Warraich","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0054","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCHEARTFAILURE.114.001825","article-title":"Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction","volume":"8","author":"Dhakal","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0055","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1152\/japplphysiol.01114.2010","article-title":"Effect of acute high-intensity interval exercise on postexercise biventricular function in mild heart failure","volume":"110","author":"Tomczak","year":"2011","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0056","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.113.001475","article-title":"Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study","volume":"128","author":"Zakeri","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0057","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/CIRCULATIONAHA.117.030093","article-title":"High prevalence of occult heart failure with preserved ejection fraction among patients with atrial fibrillation and dyspnea","volume":"137","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0058","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/eurheartj\/ehy809","article-title":"Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction","volume":"40","author":"Obokata","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0059","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jacc.2020.07.009","article-title":"Atrial dysfunction in patients with heart failure with preserved ejection fraction and atrial fibrillation","volume":"76","author":"Reddy","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0060","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cardfail.2020.12.016","article-title":"Impact of right atrial remodeling in heart failure with preserved ejection fraction","volume":"27","author":"Ikoma","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0061","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/CIRCHEARTFAILURE.113.000568","article-title":"Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: A RELAX Trial ancillary study","volume":"7","author":"Zakeri","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0062","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cardfail.2017.11.005","article-title":"Right heart dysfunction in heart failure with preserved ejection fraction: the impact of atrial fibrillation","volume":"24","author":"Gorter","year":"2018","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0063","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/ehf2.12696","article-title":"Ethnic differences in atrial fibrillation among patients with heart failure in Asia","volume":"7","author":"Tan","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0064","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.011430","article-title":"Prognostic importance of right ventricular-vascular uncoupling in acute decompensated heart failure with preserved ejection fraction","volume":"13","author":"Nakagawa","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0065","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ejhf.1699","article-title":"Functional mitral regurgitation and left atrial myopathy in heart failure with preserved ejection fraction","volume":"22","author":"Tamargo","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0066","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.1464","article-title":"Left atrial strain and compliance in the diagnostic evaluation of heart failure with preserved ejection fraction","volume":"21","author":"Reddy","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0067","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jcmg.2013.04.006","article-title":"Incremental diagnostic value of la strain with leg lifts in heart failure with preserved ejection fraction","volume":"6","author":"Obokata","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0068","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/CIRCULATIONAHA.116.024822","article-title":"Role of diastolic stress testing in the evaluation for heart failure with preserved ejection fraction: a simultaneous invasive-echocardiographic study","volume":"135","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0069","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.hfc.2018.12.004","article-title":"The role of echocardiography in heart failure with preserved ejection fraction: what do we want from imaging?","volume":"15","author":"Obokata","year":"2019","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0070","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jjcc.2021.11.003","article-title":"Echocardiography in the diagnostic evaluation and phenotyping of heart failure with preserved ejection fraction","volume":"79","author":"Harada","year":"2022","journal-title":"J Cardiol"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0071","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0072","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1093\/eurheartj\/ehy268","article-title":"Haemodynamics, dyspnoea, and pulmonary reserve in heart failure with preserved ejection fraction","volume":"39","author":"Obokata","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0073","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cardfail.2021.04.014","article-title":"Salutary acute effects of exercise on central hemodynamics in heart failure with preserved ejection fraction","volume":"27","author":"Obokata","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0074","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"40","author":"Pieske","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0075","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jchf.2020.03.013","article-title":"Application of diagnostic algorithms for heart failure with preserved ejection fraction to the community","volume":"8","author":"Selvaraj","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0076","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijcard.2021.08.001","article-title":"Performance of the H2FPEF and the HFA-PEFF scores for the diagnosis of heart failure with preserved ejection fraction in Japanese patients: a report from the Japanese multicenter registry","volume":"342","author":"Tada","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0077","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1253\/circj.CJ-20-0784","article-title":"Clinical usefulness of the HFA-PEFF diagnostic scoring system in identifying late elderly heart failure with preserved ejection fraction patients","volume":"85","author":"Seo","year":"2021","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0078","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jchf.2020.04.007","article-title":"Endomyocardial biopsy characterization of heart failure with preserved ejection fraction and prevalence of cardiac amyloidosis","volume":"8","author":"Hahn","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0079","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0080","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/mus.26034","article-title":"Estimating the global prevalence of transthyretin familial amyloid polyneuropathy","volume":"57","author":"Schmidt","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0081","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/modpathol.2011.117","article-title":"Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study","volume":"24","author":"Ueda","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0082","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1002\/ehf2.13473","article-title":"Diagnosis of wild-type transthyretin amyloid cardiomyopathy in Japan: red-flag symptom clusters and diagnostic algorithm","volume":"8","author":"Inomata","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0083","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/ehf2.12884","article-title":"Clinical characteristics and natural history of wild-type transthyretin amyloid cardiomyopathy in Japan","volume":"7","author":"Yamada","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0084","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin cardiac amyloidosis and risk stratificationusing a novel staging system","volume":"68","author":"Grogan","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0085","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.115.018852","article-title":"Heart failure resulting from age-related cardiac amyloid disease associated with wild-type transthyretin: a prospective, observational cohort study","volume":"133","author":"Connors","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0086","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jchf.2019.04.010","article-title":"Screening for transthyretin amyloid cardiomyopathy in everyday practice","volume":"7","author":"Witteles","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0087","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.cardfail.2021.04.023","article-title":"JCS\/JHFS 2021 Guideline-focused update on diagnosis and treatment of acute and chronic heart failure","volume":"27","author":"Tsutsui","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0088","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0089","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0090","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1253\/circj.CJ-19-0342","article-title":"JCS 2017\/JHFS 2017 Guideline on diagnosis and treatment of acute and chronic heart failure: digest version","volume":"83","author":"Tsutsui","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0091","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1536\/ihj.16-023","article-title":"Improves the long-term prognosis in patients with congestive heart failure with preserved ejection fraction as well as in those with reduced ejection fraction","volume":"57","author":"Imamura","year":"2016","journal-title":"Int Heart J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0092","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in the treatment of preserved cardiac function heart failure with an aldosterone antagonist (TOPCAT) trial","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0093","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/ehf2.13293","article-title":"Impact of readmissions on octogenarians with heart failure with preserved ejection fraction: PURSUIT-HFpEF registry","volume":"8","author":"Nishino","year":"2021","journal-title":"ESC Hear Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0094","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcmg.2018.12.034","article-title":"Diastolic dysfunction and heart failure with preserved ejection fraction: understanding mechanisms by using noninvasive methods","volume":"13","author":"Obokata","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0095","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jama.2015.17346","article-title":"Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial","volume":"315","author":"Kitzman","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0096","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin\u2013neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0097","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0140-6736(22)00016-2","article-title":"Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial","volume":"399","author":"Shah","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0098","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCULATIONAHA.116.021884","article-title":"Phenotype-specific treatment of heart failure with preserved ejection fraction","volume":"134","author":"Shah","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0099","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0100","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jchf.2019.09.009","article-title":"Clinical phenogroups in heart failure with preserved ejection fraction: detailed phenotypes, prognosis, and response to spironolactone","volume":"8","author":"Cohen","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0101","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ejhf.1788","article-title":"Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity","volume":"22","author":"Reddy","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0102","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jchf.2019.04.019","article-title":"Hemodynamic effects of weight loss in obesity: a systematic review and meta-analysis","volume":"7","author":"Reddy","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0103","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1161\/CIRCULATIONAHA.117.030501","article-title":"Effect of distinct lifestyle interventions on mobilization of fat storage pools: CENTRAL magnetic resonance imaging randomized controlled trial","volume":"137","author":"Gepner","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0104","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.diabres.2018.05.017","article-title":"Dapagliflozin significantly reduced liver fat accumulation associated with a decrease in abdominal subcutaneous fat in patients with inadequately controlled type 2 diabetes mellitus","volume":"142","author":"Kurinami","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12933-017-0658-8","article-title":"The effect of dapagliflozin treatment on epicardial adipose tissue volume","volume":"17","author":"Sato","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0106","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijcard.2018.06.106","article-title":"Statin therapy modulates thickness and inflammatory profile of human epicardial adipose tissue","volume":"274","author":"Parisi","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0107","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1253\/circj.CJ-14-0865","article-title":"Prognostic impact of statin use in patients with heart failure and preserved ejection fraction","volume":"79","author":"Nochioka","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0108","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1002\/ehf2.13619","article-title":"Impact of weight loss in patients with heart failure with preserved ejection fraction: results from the FLAGSHIP study","volume":"8","author":"Kamisaka","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0109","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1536\/ihj.21-195","article-title":"Underweight is associated with poor prognosis in heart failure with preserved ejection fraction","volume":"62","author":"Matsuhiro","year":"2021","journal-title":"Int Heart J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0110","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ehf2.12405","article-title":"Geriatric nutritional risk index predicts all-cause deaths in heart failure with preserved ejection fraction","volume":"6","author":"Nishi","year":"2019","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0111","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0112","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1253\/circj.CJ-19-0241","article-title":"Nationwide survey of multidisciplinary care and cardiac rehabilitation for patients with heart failure in Japan: an analysis of the AMED-CHF study","volume":"83","author":"Kamiya","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0113","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jjcc.2021.01.010","article-title":"Feasibility of home-based cardiac rehabilitation using an integrated telerehabilitation platform in elderly patients with heart failure: a pilot study","volume":"78","author":"Kikuchi","year":"2021","journal-title":"J Cardiol"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0114","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.120.050991","article-title":"Ablation versus drug therapy for atrial fibrillation in heart failure","volume":"143","author":"Packer","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jjcc.2019.02.014","article-title":"Relationships between maintenance of sinus rhythm and clinical outcomes in patients with heart failure with preserved ejection fraction and atrial fibrillation","volume":"74","author":"Machino-Ohtsuka","year":"2019","journal-title":"J Cardiol"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0116","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/jce.14369","article-title":"Catheter ablation of atrial fibrillation reduces heart failure rehospitalization in patients with heart failure with preserved ejection fraction","volume":"31","author":"Fukui","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0117","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.jacc.2013.07.020","article-title":"Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction","volume":"62","author":"Machino-Ohtsuka","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0118","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1253\/circj.CJ-18-0073","article-title":"Clinical characteristics, management, and outcomes of japanese patients hospitalized for heart failure with preserved ejection fraction: a report from the Japanese Heart Failure Syndrome With Preserved Ejection Fraction (JASPER) registry","volume":"82","author":"Nagai","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0119","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/ehf2.13302","article-title":"Prognostic significance of the HFA-PEFF score in patients with heart failure with preserved ejection fraction","volume":"8","author":"Sotomi","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0120","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.121.013495","article-title":"Cardiac power output is independently and incrementally associated with adverse outcomes in heart failure with preserved ejection fraction","volume":"15","author":"Harada","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0121","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijcard.2018.04.001","article-title":"Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction","volume":"271","author":"Streng","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0122","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.cardfail.2021.04.015","article-title":"Association between \u03b2-blockers and outcomes in heart failure with preserved ejection fraction: current insights from the SwedeHF registry","volume":"27","author":"Meyer","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0123","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ejhf.2408","article-title":"A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction: insights from the ESC-HFA EORP Heart Failure Long-Term Registry","volume":"24","author":"Kap\u0142on-Cie\u015blicka","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0124","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s12471-020-01534-7","article-title":"Clinical profile and contemporary management of patients with heart failure with preserved ejection fraction: results from the CHECK-HF registry","volume":"29","author":"Uijl","year":"2021","journal-title":"Neth Heart J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0125","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001448","article-title":"Characterisation of the patients with suspected heart failure: experience from the SHEAF registry","volume":"8","author":"Garg","year":"2021","journal-title":"Open Heart"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2019.01.006","article-title":"Long-term outcomes for heart failure patients with and without diabetes: from the Get With The Guidelines Heart Failure Registry","volume":"211","author":"Ziaeian","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0127","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/CIRCHEARTFAILURE.112.968594","article-title":"Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction a community-based study","volume":"5","author":"Mohammed","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2022.09.018_bib0128","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1536\/ihj.18-699","article-title":"Relation of systolic blood pressure on the following day with post-discharge mortality in hospitalized heart failure patients with preserved ejection fraction","volume":"60","author":"Sato","year":"2019","journal-title":"Int Heart J"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916423000076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916423000076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:48:32Z","timestamp":1761029312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916423000076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":128,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1071916423000076"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2022.09.018","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology, Pathophysiology, Diagnosis, and Therapy of Heart Failure With Preserved Ejection Fraction in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2022.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}